Align Technology Inc
F:AFW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Align Technology Inc
F:AFW
|
US |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
US |
|
Exor NV
F:EYX
|
NL |
|
M
|
MGM Resorts International
F:MGG
|
US |
|
Loomis AB
LSE:0JYZ
|
SE |
|
Ammo Inc
NASDAQ:POWW
|
US |
|
C
|
China Longyuan Power Group Corp Ltd
XBER:6WX
|
CN |
|
P
|
Persimmon PLC
SWB:OHP
|
UK |
|
Fuji Media Holdings Inc
TSE:4676
|
JP |
|
El Pollo Loco Holdings Inc
NASDAQ:LOCO
|
US |
|
Koninklijke Philips NV
LSE:0LNG
|
NL |
|
Chesapeake Utilities Corp
NYSE:CPK
|
US |
|
Great Southern Bancorp Inc
F:GS6
|
US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
RTL Group SA
OTC:RGLXF
|
LU |
|
W
|
Watts Water Technologies Inc
F:W3W
|
US |
|
I
|
Imperial Brands PLC
DUS:ITB
|
UK |
|
Audax Renovables SA
LSE:0EIB
|
ES |
|
Tubacex SA
MAD:TUB
|
ES |
|
Cantaloupe Inc
F:UTE0
|
US |
|
N
|
Nextdoor Holdings Inc
NYSE:KIND
|
US |
|
Bid Corporation Ltd
OTC:BPPPF
|
ZA |
|
H
|
Harley-Davidson Inc
SWB:HAR
|
US |
|
B
|
Broadcom Inc
XBER:1YD
|
US |
Align Technology Inc
Align Technology makes clear dental aligners and the digital tools that go with them. Its best-known product is Invisalign, a custom plastic system used to straighten teeth without metal braces. The company also sells scanners, software, and related services that help dentists and orthodontists plan and monitor treatment. Its main customers are dental professionals, orthodontists, and other oral care providers who buy the systems and use them in their practices. Align makes money by selling aligners for each patient case, along with scanners and software that support treatment planning and workflow. Patients are the end users, but the business is built around selling to the professionals who prescribe and deliver care. What makes Align different is that it sits at the intersection of healthcare and digital manufacturing. It combines 3D imaging, treatment software, and custom-made orthodontic products into one system. That gives it a role not just as a medical device maker, but as a technology supplier that helps dental practices offer a more predictable, branded clear-aligner treatment option.
Align Technology makes clear dental aligners and the digital tools that go with them. Its best-known product is Invisalign, a custom plastic system used to straighten teeth without metal braces. The company also sells scanners, software, and related services that help dentists and orthodontists plan and monitor treatment.
Its main customers are dental professionals, orthodontists, and other oral care providers who buy the systems and use them in their practices. Align makes money by selling aligners for each patient case, along with scanners and software that support treatment planning and workflow. Patients are the end users, but the business is built around selling to the professionals who prescribe and deliver care.
What makes Align different is that it sits at the intersection of healthcare and digital manufacturing. It combines 3D imaging, treatment software, and custom-made orthodontic products into one system. That gives it a role not just as a medical device maker, but as a technology supplier that helps dental practices offer a more predictable, branded clear-aligner treatment option.
Beat and raise posture: Align said Q1 was better than expected, with revenue of $1.04 billion, record clear aligner shipments of 686,000 cases, and margin performance above outlook.
Demand strength: Clear aligner volumes grew across regions, led by double-digit growth internationally, while North America remained stable to slightly down and retail traffic was softer.
Guidance held: Management reaffirmed full-year 2026 guidance and gave Q2 revenue guidance of $1.04 billion to $1.06 billion, while taking a cautious stance because of Middle East uncertainty and macro risk.
Margin lift: Gross margin and operating margin improved year over year, helped by higher ASPs, operational efficiencies, and a better mix of lower-refinement products.
Capital return: Align completed its prior $200 million buyback plan and announced another $200 million repurchase program over the next six months.
Strategic growth: Management highlighted progress in DSOs, patient financing, treatment planning services, and new product areas like zero-refinement configurations, direct printing, and restorative dentistry.
